SCHEMBL8098167

SCHEMBL8098167

CC(C)C(=O)NC[C@@H]1C[C@H]1c1cccc(F)c1

nearest known ligand 0.51

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 5/20 0.51
HTR2A P28223 1/20 0.51
HTR2B P41595 1/20 0.51
MTNR1A P48039 6/20 0.49
MTNR1B P49286 6/20 0.49
GRIA4 P48058 1/20 0.42
DRD2 P14416 2/20 0.41
DRD1 P21728 2/20 0.41
DRD4 P21917 2/20 0.41
DRD3 P35462 2/20 0.41
CNR1 P21554 1/20 0.40
GPR88 Q9GZN0 1/20 0.38
NOS3 P29474 1/20 0.38
NOS1 P29475 1/20 0.38
NOS2 P35228 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8098166 1.00 HTR2C (0.51) HTR2CHTR2AHTR2BMTNR1AMTNR1B
SCHEMBL8088677 0.86 HTR2C (0.52) HTR2CHTR2AHTR2BMTNR1AMTNR1B
SCHEMBL8088680 0.86 HTR2C (0.52) HTR2CHTR2AHTR2BMTNR1AMTNR1B
SCHEMBL8102256 0.84 HTR2C (0.54) HTR2CHTR2AHTR2BMTNR1AMTNR1B
SCHEMBL8102259 0.84 HTR2C (0.54) HTR2CHTR2AHTR2BMTNR1AMTNR1B
SCHEMBL8088503 0.82 HTR2A (0.56) HTR2CHTR2AHTR2BMTNR1AMTNR1B
SCHEMBL8088502 0.82 HTR2A (0.56) HTR2CHTR2AHTR2BMTNR1AMTNR1B
SCHEMBL8088842 0.81 MTNR1B (0.51) HTR2CHTR2AHTR2BMTNR1AMTNR1B
SCHEMBL8088845 0.81 MTNR1B (0.51) HTR2CHTR2AHTR2BMTNR1AMTNR1B
SCHEMBL14568837 0.78 HTR2C (0.65) HTR2CHTR2AHTR2BNOS3NOS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0747346-B1 N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics BRISTOL MYERS SQUIBB CO (US) 2000-02-16 EP disclosed
EP-0747346-A2 N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics BRISTOL-MYERS SQUIBB COMPANY (US) 1996-12-11 EP disclosed